Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 11, 2022EBioMedicineOpen Access

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses

View Full Paper
Ask AI
Bookmark
Share

Design

Preclinical

Authors

PHPeter HalfmannUniversity of North Carolina at Chapel HillSFSteven J. FreyGeorgia Institute of TechnologyKLKathryn LoefflerGeorgia Institute of Technology

Discussion

Loading...

Member takes

Implication

Multivalent S2-based vaccines may offer broad protection against various SARS-CoV-2 variants and related coronaviruses.

Structured PICO

I
Intervention
Multivalent S2-based vaccines
O
Outcome
Protection against SARS-CoV-2 variants of concern and pangolin coronaviruses

Multivalent S2-based vaccines may offer broad protection against various SARS-CoV-2 variants and related coronaviruses.

Cite This Study

Halfmann et al. (2022) studied this question.

synapsesocial.com/papers/69d7d962319e71454dbedc32https://doi.org/10.1016/j.ebiom.2022.104341
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit2020 · 228 citations
  2. 2SARS-like WIV1-CoV poised for human emergence2016 · 490 citations
  3. 3Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease2022 · 23 citations